Inkabb (Hk) Biotechnology Company Limited Company Information

Current Status : Live


Inkabb (Hk) Biotechnology Company Limited's Hong Kong CR Number is 2939805. Incorporation Date is 08-MAY-2020. It's Winding up Mode is None. Dissolution date is None. Inkabb (Hk) Biotechnology Company Limited company is of Private company limited by shares Type.
Additional Remarks on the Inkabb (Hk) Biotechnology Company Limited company are None.

Company Data

CRN2939805
Company NameINKABB (HK) Biotechnology Company Limited
Chinese Name英卡比進出口貿易有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up ModeNone
Date of Incorporation08-MAY-2020
See companies with same Incorporation Date - 08-MAY-2020
Date of DissolutionNone
RemarksNone
Important NoteNone
Tagshk   inkabb   biotechnology   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
INKABB (HK) Biotechnology Company Limited英卡比進出口貿易有限公司08-MAY-2020

FAQs:

When was Inkabb (Hk) Biotechnology Company Limited incorporated?

Inkabb (Hk) Biotechnology Company Limited was incorporated on 08-MAY-2020 in Hongkong.

What is the type of Inkabb (Hk) Biotechnology Company Limited?

Inkabb (Hk) Biotechnology Company Limited is classified as Private company limited by shares.

What is the current status of Inkabb (Hk) Biotechnology Company Limited Company?

The status of Inkabb (Hk) Biotechnology Company Limited is Live.

What is the CR Number of Inkabb (Hk) Biotechnology Company Limited?

The CR Number of Inkabb (Hk) Biotechnology Company Limited is 2939805.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Inkabb (Hk) Biotechnology Company Limited. The official registry should always be referred for latest information.

Last Updated on 02-11-2020.

Check other companies added on 02-11-2020

Check out Companies Incorporated on 08-MAY-2020: